Your browser doesn't support javascript.
loading
Inhibition of tumor-associated macrophages by trabectedin improves the antitumor adaptive immunity in response to anti-PD-1 therapy.
Belgiovine, Cristina; Frapolli, Roberta; Liguori, Manuela; Digifico, Elisabeth; Colombo, Federico Simone; Meroni, Marina; Allavena, Paola; D'Incalci, Maurizio.
Affiliation
  • Belgiovine C; Humanitas Clinical and Research Center - IRCCS, via Manzoni 56, Rozzano, Milan, 20089, Italy.
  • Frapolli R; Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
  • Liguori M; Humanitas Clinical and Research Center - IRCCS, via Manzoni 56, Rozzano, Milan, 20089, Italy.
  • Digifico E; Humanitas Clinical and Research Center - IRCCS, via Manzoni 56, Rozzano, Milan, 20089, Italy.
  • Colombo FS; Humanitas Clinical and Research Center - IRCCS, via Manzoni 56, Rozzano, Milan, 20089, Italy.
  • Meroni M; Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
  • Allavena P; Humanitas Clinical and Research Center - IRCCS, via Manzoni 56, Rozzano, Milan, 20089, Italy.
  • D'Incalci M; Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Eur J Immunol ; 51(11): 2677-2686, 2021 11.
Article in En | MEDLINE | ID: mdl-34570376
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Antineoplastic Agents, Alkylating / Adaptive Immunity / Trabectedin / Tumor-Associated Macrophages / Neoplasms, Experimental Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals Language: En Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Antineoplastic Agents, Alkylating / Adaptive Immunity / Trabectedin / Tumor-Associated Macrophages / Neoplasms, Experimental Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals Language: En Year: 2021 Type: Article